Fuyuan Pharmaceutical is a high-tech pharmaceutical enterprise integrating R&D, production and sales of new drugs. The company focuses on cardiovascular and neurological fields, and has developed national patented products such as olmesartan medoxomil and compound alpha-keto acid. Listed on the main board of the Shanghai Stock Exchange today, the company’s stock code is 601089, the issue price is 14.62 yuan per share, and the issue price-earnings ratio is 22.98 times.
This article is reproduced from: https://www.itjuzi.com/investevent/13312484
This site is for inclusion only, and the copyright belongs to the original author.